- Home
- REPL vs CECO Comparison
REPL vs CECO Comparison
Compare REPL & CECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- CECO
- Stock Information
- Founded
- REPL 2015
- CECO 1966
- Country
- REPL United States
- CECO United States
- Employees
- REPL N/A
- CECO N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- CECO Pollution Control Equipment
- Sector
- REPL Health Care
- CECO Industrials
- Exchange
- REPL Nasdaq
- CECO Nasdaq
- Market Cap
- REPL 578.4M
- CECO 632.8M
- IPO Year
- REPL 2018
- CECO N/A
- Fundamental
- Price
- REPL $7.71
- CECO $25.01
- Analyst Decision
- REPL Strong Buy
- CECO Strong Buy
- Analyst Count
- REPL 6
- CECO 5
- Target Price
- REPL $20.00
- CECO $36.00
- AVG Volume (30 Days)
- REPL 1.1M
- CECO 325.2K
- Earning Date
- REPL 05-19-2025
- CECO 04-29-2025
- Dividend Yield
- REPL N/A
- CECO N/A
- EPS Growth
- REPL N/A
- CECO 273.86
- EPS
- REPL N/A
- CECO 1.30
- Revenue
- REPL N/A
- CECO $608,298,000.00
- Revenue This Year
- REPL $31.16
- CECO $28.09
- Revenue Next Year
- REPL N/A
- CECO $9.08
- P/E Ratio
- REPL N/A
- CECO $19.18
- Revenue Growth
- REPL N/A
- CECO 8.89
- 52 Week Low
- REPL $4.92
- CECO $17.57
- 52 Week High
- REPL $17.00
- CECO $35.16
- Technical
- Relative Strength Index (RSI)
- REPL 39.21
- CECO 62.47
- Support Level
- REPL $6.93
- CECO $24.77
- Resistance Level
- REPL $10.30
- CECO $25.94
- Average True Range (ATR)
- REPL 0.73
- CECO 1.28
- MACD
- REPL -0.07
- CECO 0.62
- Stochastic Oscillator
- REPL 23.15
- CECO 85.61
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About CECO CECO Environmental Corp.
CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.